Paul Tudor Jones’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.9K Sell
24,237
-39,343
-62% -$96.1K ﹤0.01% 3425
2026
Q1
$151K Buy
+63,580
New +$220K ﹤0.01% 3415
2025
Q3
Sell
-15,525
Closed -$56.8K 3724
2025
Q2
$56.8K Sell
15,525
-25,053
-62% -$93.4K ﹤0.01% 3166
2025
Q1
$175K Sell
40,578
-23,743
-37% -$95.9K ﹤0.01% 2889
2024
Q4
$206K Buy
+64,321
New +$216K ﹤0.01% 2832
2024
Q3
Sell
-60,809
Closed -$170K 2999
2024
Q2
$170K Sell
60,809
-3,504
-5% -$9.4K ﹤0.01% 2174
2024
Q1
$183K Sell
64,313
-83
-0.1% -$282 ﹤0.01% 2052
2023
Q4
$263K Buy
64,396
+24,785
+63% +$69.4K ﹤0.01% 2087
2023
Q3
$126K Sell
39,611
-24,721
-38% -$78.6K ﹤0.01% 2134
2023
Q2
$214K Buy
64,332
+39,171
+156% +$116K ﹤0.01% 2196
2023
Q1
$54K Buy
+25,161
New +$62.2K ﹤0.01% 2283
2022
Q3
Sell
-21,572
Closed -$105K 2594
2022
Q2
$105K Buy
+21,572
New +$133K ﹤0.01% 1918
2020
Q1
Sell
-15,000
Closed -$72K 1246
2019
Q4
$72K Buy
+15,000
New +$95.1K ﹤0.01% 1070

Other funds holding ORGO

Paul Tudor Jones's ORGO Position: Q2 2026 in Review

Paul Tudor Jones reduced its Organogenesis Holdings (ORGO) stake by 62% in Q2 2026, selling an estimated $96.1K and leaving 24,237 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3425.

Paul Tudor Jones first reported a position in ORGO in Q4 2019 and has held it in 13 quarters since. The position peaked at $263K in Q4 2023. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Paul Tudor Jones held 24,237 shares of Organogenesis Holdings worth $58.9K as of Q2 2026.
  • Paul Tudor Jones sold 39,343 Organogenesis Holdings shares in Q2 2026, an estimated $96.1K.
  • Organogenesis Holdings made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3425 holding.
  • Paul Tudor Jones first reported a position in Organogenesis Holdings in Q4 2019 and has held it in 13 quarters since.
  • Paul Tudor Jones's Organogenesis Holdings position peaked at $263K in Q4 2023.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.